#153381

Anti-CEA [337]

Cat. #153381

Anti-CEA [337]

Cat. #: 153381

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: CEA

Class: Monoclonal

Application: ELISA ; FACS ; IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lindy Durrant

Institute: University of Nottingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CEA [337]
  • Alternate name: CEACAM5; CEA
  • Clone: 337
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: C57BL/6
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC
  • Description: Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains.
  • Immunogen: CEA

Target Details

  • Target: CEA
  • Target background: Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains.

Applications

  • Application: ELISA ; FACS ; IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Shipping at 4° C

References

  • Byers et al. 1988. J Immunol. 140(11):4050-5. PMID: 2453564.
  • Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.